Natural killer cells in antitumour adoptive cell immunotherapy

TJ Laskowski, A Biederstädt, K Rezvani - Nature Reviews Cancer, 2022 - nature.com
Natural killer (NK) cells comprise a unique population of innate lymphoid cells endowed with
intrinsic abilities to identify and eliminate virally infected cells and tumour cells. Possessing …

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

D Bruni, HK Angell, J Galon - Nature Reviews Cancer, 2020 - nature.com
Abstract The international American Joint Committee on Cancer/Union for International
Cancer Control (AJCC/UICC) tumour-node-metastasis (TNM) staging system provides the …

Key chemokines direct migration of immune cells in solid tumors

K Kohli, VG Pillarisetty, TS Kim - Cancer gene therapy, 2022 - nature.com
Immune cell infiltration into solid tumors, their movement within the tumor microenvironment
(TME), and interaction with other immune cells are controlled by their directed migration …

Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer

C Vernieri, G Fucà, F Ligorio, V Huber, A Vingiani… - Cancer Discovery, 2022 - AACR
In tumor-bearing mice, cyclic fasting or fasting-mimicking diets (FMD) enhance the activity of
antineoplastic treatments by modulating systemic metabolism and boosting antitumor …

CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma

G Wang, Z Zhang, K Zhong, Z Wang, N Yang, X Tang… - Molecular Therapy, 2023 - cell.com
Glioblastoma (GBM) is the most aggressive primary malignant brain cancer and urgently
requires effective treatments. Chimeric antigen receptor T (CAR-T) cell therapy offers a …

Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment

H Harjunpää, M Llort Asens, C Guenther… - Frontiers in …, 2019 - frontiersin.org
The immune system and cancer have a complex relationship with the immune system
playing a dual role in tumor development. The effector cells of the immune system can …

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

F Finotello, C Mayer, C Plattner, G Laschober… - Genome medicine, 2019 - Springer
We introduce quanTIseq, a method to quantify the fractions of ten immune cell types from
bulk RNA-sequencing data. quanTIseq was extensively validated in blood and tumor …

Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy

MT Chow, AJ Ozga, RL Servis, DT Frederick, JA Lo… - Immunity, 2019 - cell.com
Despite compelling rates of durable clinical responses to programmed cell death-1 (PD-1)
blockade, advances are needed to extend these benefits to resistant tumors. We found that …

Tumor immunology and tumor evolution: intertwined histories

J Galon, D Bruni - Immunity, 2020 - cell.com
Cancer is a complex disease whose outcome depends largely on the cross-talk between the
tumor and its microenvironment. Here, we review the evolution of the field of tumor …

The consensus molecular subtypes of colorectal cancer

J Guinney, R Dienstmann, X Wang, A De Reynies… - Nature medicine, 2015 - nature.com
Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and
drug responses. To resolve inconsistencies among the reported gene expression–based …